Dr. Lee is a seasoned and successful senior executive in the biotech and pharmaceutical industries, boasting more than two decades of impressive leadership and accomplishments across a diverse range of organizations, stages of development, therapeutic domains, and global settings.
EDUCATION
- MBA, The Wharton School, University of Pennsylvania, USA
- MPH, Seoul National University College of Public Health, Korea
- Medical Doctor, Hallym University College of Medicine, Korea
CORE COMPETENCIES
- Leadership, Team Building, Fund Raising, Stakeholder Management, Strategy Building & Execution, Market Insight, Sales Development and Budget Management
PROFESSIONAL EXPERIENCE :
+10 years of leading various bio-pharma companies
- CEO and Board of Directors in Shaperon Inc. Completed KOSDAQ listing in 2022 and led 2 phase II clinical trials of atopic dermatitis and Covid-19 treatment.
- President and General Manager in Mundipharma Korea.
- General Manager in Abbott Korea.
- President and General Manager in Eli Lilly & Co Philippines.
- Co-founder in Etechtransfer.com, USA.
- Board of directors in Pharmascience Korea and Innocure Therapeutics.
